Cargando…

Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are heterogeneous rare diseases causing malnutrition and cachexia in which the study of body composition may have an impact in prognosis. In this context, we aimed to evaluate muscle and fat tissues by computed tomography (CT) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebastian-Valles, Fernando, Sánchez de la Blanca Carrero, Nuria, Rodríguez-Laval, Víctor, Martinez-Hernández, Rebeca, Serrano-Somavilla, Ana, Knott-Torcal, Carolina, Muñoz de Nova, José Luis, Martín-Pérez, Elena, Marazuela, Mónica, Sampedro-Nuñez, Miguel Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654293/ https://www.ncbi.nlm.nih.gov/pubmed/36358607 http://dx.doi.org/10.3390/cancers14215189

Ejemplares similares

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response
por: Sebastian-Valles, Fernando, et al.
Publicado: (2023)

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus
por: Ruiz-Roso, María Belén, et al.
Publicado: (2020)

Circulating microRNAs in Breast Milk and Their Potential Impact on the Infant
por: Carrillo-Lozano, Elena, et al.
Publicado: (2020)

Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings
por: Ramos-Leví, Ana M., et al.
Publicado: (2018)

Finding answers in lipid profile in COVID-19 patients
por: Sampedro-Nuñez, M., et al.
Publicado: (2021)

Analysis of Expression of Different Histone Deacetylases in Autoimmune Thyroid Disease
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2021)

Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases
por: Martínez-Hernández, Rebeca, et al.
Publicado: (2019)

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT
por: Oladejo, A.O.
Publicado: (2009)

mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
por: Zanini, Sara, et al.
Publicado: (2020)

LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2020)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors
por: Sebastian-Valles, Fernando, et al.
Publicado: (2023)

Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2018)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)

Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center
por: Butz, Frederike, et al.
Publicado: (2023)

Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus
por: Pla, Begoña, et al.
Publicado: (2020)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

PET and PET/CT with (68)Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
por: Sollini, Martina, et al.
Publicado: (2014)

Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
por: Kim, Seung Tae, et al.
Publicado: (2016)

Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues
por: Anthony, Lowell B., et al.
Publicado: (2021)

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters
por: Luque, Raul M., et al.
Publicado: (2015)

Duodenal gangliocytic paraganglioma, a rare entity among GEP-NET: a case report with immunohistochemical and molecular study
por: Tatangelo, Fabiana, et al.
Publicado: (2014)

Prospective Multicentric Assessment of (68)Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
por: Lugat, Alexandre, et al.
Publicado: (2023)

Biochemical diagnosis of neuroendocrine GEP tumor.
por: Oberg, K.
Publicado: (1997)

GEPS: the Gene Expression Pattern Scanner
por: Wang, Yu-Peng, et al.
Publicado: (2006)

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2015)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Graves’ Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells
por: Leskela, Susanna, et al.
Publicado: (2015)

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study
por: Cho, Mee-Yon, et al.
Publicado: (2012)

Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
por: Xue, Mingzhan, et al.
Publicado: (2017)

Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET
por: Ohlsson, Håkan, et al.
Publicado: (2022)

Grid-Brick Event Processing Framework in GEPS
por: Amorim, A, et al.
Publicado: (2003)

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
por: Ferrata, Martina, et al.
Publicado: (2019)

Alpelisib-Induced Diabetes Mellitus: Case Report, Pharmacodynamics and Management Considerations
por: Pla Peris, Begoña, et al.
Publicado: (2022)

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2015)

Time from first tumor manifestation to diagnosis in patients with GEP-NET: Results from a large German tertiary referral center
por: Koch, Christine, et al.
Publicado: (2021)

[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Characterizing the Specific Recognition of Xanthurenic Acid by GEP1 and GEP1-GCα Interactions in cGMP Signaling Pathway in Gametogenesis of Malaria Parasites
por: Zhu, Cheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vfmm5ghrbh3hq97v820injg7pn